Research programme: diamorphine analogue vaccine - Opiant PharmaceuticalsAlternative Names: Adjuvanted heroin analogue vaccine - Opiant; Heroin vaccine - Opiant
Latest Information Update: 05 Nov 2016
At a glance
- Originator National Institute on Drug Abuse; Walter Reed Army Institute of Research
- Developer National Institute on Drug Abuse; Opiant Pharmaceuticals; Walter Reed Army Institute of Research
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Heroin abuse